Topic: Urology

Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its LithoVue Elite single-use […]

There’s a major lack of male fertility specialists across the country, which means many couples […]

Withings, a company that makes connected medical devices, announced on Tuesday that it is developing […]

Advanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in […]

MedAlliance announced today that it enrolled the first patient in a trial for its drug-eluting […]

Neuspera Medical recently announced it will begin enrolment in its pivotal clinical trial, SANS-UUI—a single-arm […]

Zeus reported a multi-million-dollar investment to expand its catheter manufacturing capacity worldwide. The first phase of […]

Biomerics this week announced it opened a 2,000 sq. ft research and development facility in […]

Biomerics, a contract manufacturer serving the interventional device market, has just opened a new Balloons […]

Researchers at the University of California Los Angeles have created a zwitterion polymer coating for […]

Ethicon, a Johnson & Johnson MedTech company, announced the news that should bring back some […]

Teleflex (NYSE:TFX) announced today that it launched its UroLift system for treating benign prostatic hyperplasia (BPH) […]

Meghan Scanlon, Boston Scientific’s president of urology and pelvic health, discusses the field and the […]

Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global […]

Researchers at RMIT University in Melbourne, Australia, created an AI system that can identify prostate […]

Horizon Technology Finance Corporation announced yesterday that it provided a $5 million venture loan to Corinth […]

Medtronic has announced it has been implanted the first patient in its evaluation of InterStim […]

The $4 million equity investment will support the company in optimizing its product design and […]

Two-year results of Axonics’ ARTISAN-sacral neuromodulation (SNM) study demonstrate that patients implanted with the r-SNM […]

Medtronic has landed FDA approval for its InterStim Micro neurostimulator and the matching InterStim SureScan […]

Axonics, a company that has developed and is commercialising novel implantable sacral neuromodulation (SNM) devices […]

AdaptHealth (NSDQ:AHCO) announced today that it upsized and priced an underwritten offering of common stock at […]

Ambu, a Danish company, is releasing a single-use flexible cystoscope. Used for visualization within the […]

Xenocor, a Salt Lake City company, won FDA clearance for its Xenoscope 5mm articulating disposable […]

Olympus (TYO:7733) announced today that it received FDA de Novo classification for its iTind non-surgical device […]

Medi-Tate, based in Israel, has won FDA de novo authorization for its iTind system to […]

Dive Brief: Axonics Modulation Technologies has given a bullish assessment of its near-term chances of […]

Dive Brief: FDA has granted De Novo authorization to Medi-Tate’s benign prostatic hyperplasia (BPH) device, the […]

Emagine Solutions Technology, a startup based in Tucson, Arizona, won FDA clearance for its VistaScan […]

Serenno Medical, an Israeli firm, has unveiled its Sentinel automatic device for monitoring and detecting […]

Dive Brief: Contura has earned FDA approval for an injectable hydrogel to treat stress urinary […]

The sacral neuromodulation market continues to see disruption as Medtronic scores a CE mark for its InterStim […]

Researchers at the University of Bath have developed a simple point-of-care test for urinary tract […]

Sacral neuromodulation device-maker Axonics Modulation Technologies (NSDQ:AXNX) announced today that it won nine utility patents from the […]

Siemens Healthineers is releasing a couple of AI-driven and cloud-based software applications, one for the […]

Renovia has received a nod from FDA for a next-generation pelvic digital therapeutic. The Boston-based […]

Surgeons at the Cleveland Clinic managed to implant a donor kidney into a patient using […]

Coloplast (CPH:COLO-B) officials have decided to keep the company’s interventional urology business — about five months […]

Predictive health company Potrero Medical today filed an SEC Form D/A disclosing the sale of nearly $5.5 […]